News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Valence Life Sciences GP II LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/12/2016 |
4
| Valence Life Sciences GP II LLC (Member of a 10% Group) has filed a Form 4 on Celator Pharmaceuticals Inc|
Txns:
| Disposed of 44,740 warrants
@ $3.58, valued at
$160.2k
Unknown transaction of 1,039,109 shares
@ $30.25, valued at
$31.4M
Unknown transaction of 143,986 shares
@ $30.25, valued at
$4.4M
Disposed of 314,611 warrants
@ $3.58, valued at
$1.1M
|
|
| 06/22/2016 |
4
| Valence Life Sciences GP II LLC (Member of a 10% Group) has filed a Form 4 on Celator Pharmaceuticals Inc|
Txns:
| Gifted 84,503 shares
@ $0
Gifted 28,000 shares
@ $0 |
|
| 10/02/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/12/2014 |
4
| Valence Life Sciences GP II LLC (Member of a 10% Group) has filed a Form 4 on Celator Pharmaceuticals Inc|
Txns:
| Disposed of 1,669,138 shares
@ $0
Disposed of 95,945 shares
@ $0
Acquired 1,123,612 shares
@ $0
Acquired 159,786 shares
@ $0
Disposed of 467,358 warrants
@ $3.58, valued at
$1.7M
Disposed of 26,864 warrants
@ $3.58, valued at
$96.2k
Acquired 314,611 warrants
@ $3.58, valued at
$1.1M
Acquired 44,740 warrants
@ $3.58, valued at
$160.2k
|
|
| 02/12/2014 |
SC 13D/A
| Valence Life Sciences GP II LLC reports a 10.8% stake in Celator Pharmaceuticals, Inc. |
| 05/09/2013 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 05/09/2013 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
|
|